Gayatri BioOrga. (524564)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarter net loss is only ₹-0 Cr, so absolute cash burn is currently negligible.
• Reported ROE of 2.44% is positive, suggesting some equity earnings support despite poor operations.
• Low absolute market cap of ₹48 Cr means even a small revival in sales could move the stock sharply.

Concerns

• Latest quarter sales are ₹0 Cr, leaving no visible operating revenue.
• ROCE of -40.72% and Piotroski F-Score of 2/9 signal severe capital destruction and financial distress.
• Profit growth is -37.50%, with zero dividend and a meaningless P/E of 0.00.
• Stock price of ₹6.13 is below the stated 52-week low of ₹9.84, and book value, promoter holding, and debt/equity are all unavailable.

AI Analysis

Let me start with what Graham called the first requirement: don't lose money. Gayatri BioOrga fails that test. This is a ₹48 crore commodity chemical company with zero sales in the latest quarter and a net profit of ₹-0 Cr. A P/E of 0.00 is not cheap; it is meaningless because there are no positive earnings to pay for. Return on capital employed is -40.72%, so every rupee used in the business is being destroyed. The Piotroski F-Score of 2 out of 9 confirms a deteriorating balance sheet. The reported ROE of 2.44% looks like an accounting leftover, not a sign of moat, and profit growth has already fallen 37.50%. The current price of ₹6.13 is actually below the reported 52-week range of ₹9.84 to ₹20.25; that tells me the market has lost faith, and in commodity chemicals without pricing power, faith is all you have. There is no book value, no promoter holding figure, no FairStock score — in other words, no data to build a margin of safety. A business with no sales, negative capital efficiency, no dividend, and an F-Score of 2 is not an investment; it is a lottery ticket. I cannot value it. I would rather miss the chance of a turnaround than risk permanent capital. If operations restart, if sales and ROCE turn positive, and if management discloses ownership and debt clearly, I will revisit. Until then, in the words of Buffett: the trick is to be patient and wait for the fat pitch. This is not even a pitch.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer